|About||The first plant in Thailand to incorporate the entire manufacturing process, from the active pharmaceutical ingredients to the finished products, utilizing state-of-the-art Japanese technology in order to distribute its products to all markets.|
Through utilizing Japanese technology and the effort of all employees, today Thai Meiji Pharmaceutical Company Limited is ever committed to improve the efficiency of the manufacture of pharmaceuticals as well as the development of new products to serve both domestic and export markets. Another important factor for the company is its policy to expand its manufacturing base to meet the demands of domestic and international consumers for internationally standardized pharmaceuticals.
Apart from its pharmaceutical business, Thai Meiji Pharmaceutical Company Limited is committed towards social
responsibility and organizes various social projects such as fund raising, donations to charities, support to
medical services, and blood donations for the Thai Red Cross Society. The company firmly believes that the quality of society is the responsibility of its members.
Since its establishment, Thai Meiji Pharmaceutical Company Limited has always been committed to the supply
of the quality pharmaceutical and veterinary products with the development of manufacturing technology,
using the highest quality raw materials and state-of-the-art machinery, supervised by expert personnel. Thai Meiji
Pharmaceutical Company Limited will always strive to develop and continue to move forward to create the highest
quality pharmaceuticals and veterinary products, hand in hand with Thai society to serve the entire world.
On November 1st 1979, Thai Meiji Pharmaceutical Company Limited established a pharmaceutical company with the manufacturing plant located at Ladkrabang Industrial Estate as a joint venture between Thai and Japanese investors.Thai Meiji Pharmaceutical Company Limited became the first plant in Thailand to incorporate the entire manufacturing process, from the active pharmaceutical ingredients to the finished products, utilizing state-of-the-art Japanese technology in order to distribute its products to domestic and international markets.
|Awards||Good Manufacturing Practice:GMP|
|Founded||November 1, 1979 (In Thailand)|
Scope Of Business
1. Domestic market
1.1 Human group products: distributed in hospitals and drugstores.
• Antibiotics such as Meiact, Fosmicin, Miotin, Meicelin, Meixil
• Gastrointestinal products such as Niflec, Meioligo
• Bone and joint medication such as Adant, Glusamine
• Other medicines such as Isodine
1.2 Veterinary group products: distributed in feedmills and farms such as Colistin, Kanamycin, Gentamicin and Meixil Vet
2. International market: distributed both Human and Veterinary products to various countries such as Japan,Korea, China, Indonesia, Malaysia,Vietnam, Singapore, Pakistan, and Ireland.